Search clinical trials for: REC-4881

Total 1409 results

Recursion Pharmaceuticals Inc.

Recruiting

A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation

Solid Tumor | APC Gene Mutation | AXIN1 Gene Mutation

United States
Recursion Pharmaceuticals Inc.

Recruiting

Evaluate REC-4881 in Patients With FAP (TUPELO)

Familial Adenomatous Polyposis

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Early-goal Directed Automated Red Blood Cell Exchange for Acute Chest Syndrome in Sickle Cell Disease (ARCAD)

Acute Chest Syndrome

France
Tel Aviv University
Wolfson Medical Center

Completed

Effects of Red Grape Cells (RGC) Powder in Type 2 Diabetics (RGC-T2D)

Type 2 Diabetes

Israel
Emory University

Terminated

Physiologic Effects of RBC Transfusion

Red Blood Cell Transfusion

United States
Westat
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients (RBC-IMPACT)

Sickle Cell Disease | Thalassemia | Pediatric Cancer

United States, Brazil
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...

Completed

Rhinopharyngeal Retrograde Clearance is Effective to Adequate Upper Airways Function in Adults

Nasal Obstruction | Exposure to Pollution

Brazil
Nanjing Zenshine Pharmaceuticals

Recruiting

Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

United States
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China
The Hospital for Sick Children
Karolinska University Hospital; Sunnybrook Health Sciences Centre; University... and other collaborators

Recruiting

RIC-NEC Randomized Controlled Trial (RIC-NEC)

Necrotizing Enterocolitis

United States, Canada
Agios Pharmaceuticals, Inc.

Completed

A Safety and Pharmacokinetic Study of AG-881 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881

Healthy Male Participants

United States
Comanche Biopharma

Recruiting

Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects

Healthy Volunteer Study

United States
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Effects of Transfusion of Older Stored Red Cells

Sickle Cell Disease | Thalassemia

United States
Bayer

Completed

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Fibrosis | Renal Insufficiency | Kidney Failure

United States
Bayer

Completed

Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction

Myocardial Infarction

United States, Argentina
ES Therapeutics Australia Pty Ltd

Withdrawn

ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors

Epilepsy; Seizure
Halscion, Inc.

Completed

Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181

Keloid

Bahamas
GlaxoSmithKline

Completed

CV Events in Emetogenic Chemotherapy

Vomiting | Cardiovascular Event | Arterial Thromboembolic Event
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Duration of Red Blood Cell Storage Prior to Transfusion

Iron, Blood Level Abnormal

United States
Bayer

Completed

Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries

Peripheral Vascular Disease
Bayer

Completed

Magnevist Post-marketing Surveillance in Japan

Diagnostic Imaging

Japan
ES Therapeutics Australia Pty Ltd

Recruiting

Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors

Tremor, Essential

Canada
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis

Psoriasis

China
Fertiga, Belgium
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...

Active, not recruiting

Aurora Test for Patients Treated With Recombinant Gonadotropins (AURORA-REC)

Infertility

Belgium
RECORDATI GROUP

Completed

Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury

Neurogenic Detrusor Overactivity

Czechia, France, Poland, Portugal
Bayer

Completed

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography

Peripheral Vascular Diseases | Peripheral Arterial Diseases | Magnetic Resonance Angiography

Japan
Halscion, Inc.

Completed

MF-4181 for the Reduction of Scars Secondary to Abdominoplasty or Laparoscopy/Laparotomy Gynecologic Procedures

Scars

Poland
Servier
Servier Pharmaceuticals, LLC

Available

Vorasidenib Expanded Access Program

Pathologic Processes | Glioma | Neoplasms | Neoplasms by Histologic Type | Neoplasms, Glandular and Epithelial | Recurrence | Disease Attributes | Neoplasms, Germ Cell and Embryonal | Neoplasms, Neuroepithelial | Neuroectodermal Tumors | Neoplasms, Nerve Tissue
Recursion Pharmaceuticals Inc.

Active, not recruiting

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 (SYCAMORE)

Cerebral Cavernous Malformation

United States
Eye & ENT Hospital of Fudan University
Shandong Provincial Hospital; Children's Hospital of Fudan University; Xinhua... and other collaborators

Recruiting

IOBT Versus IO-Rec for Hypertropia With IOOA (IIHIOOA)

Hypertropia | Inferior Oblique Overaction

China
Alfredo Gamboa
Vanderbilt University Medical Center

Withdrawn

Breathing Device for Orthostatic Hypotension (OH)

Orthostatic Hypotension

United States
Terumo BCTbio
United States Department of Defense; U.S. Army Medical Research and Development... and other collaborators

Terminated

Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion (PRAISE) (PRAISE)

Transfusion Dependent Thalassemia

United States, Israel, Italy, Turkey
Bayer

Completed

Gadobutrol Magnevist-controlled Body Study

Magnetic Resonance Imaging

China, Korea, Republic of, Japan
Institut de Recherches Internationales Servier

Active, not recruiting

Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)

Recurrent Glioma | Grade 2 Glioma | Residual Glioma

United States, Canada, Spain, Italy, United Kingdom, Switzerland, Israel, Japan, Netherlands, Germany, France
Alaa Fouli Gaber Ebrahim

Unknown

Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle

Ovarian Stimulation in ICSI

Egypt
Institut de Recherches Internationales Servier

Completed

A Study of Vorasidenib in Participants With Moderate or Mild Hepatic Impairment and Matched Participants With Normal Hepatic Function

Hepatic Impairment

United States
Bayer

Completed

Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients

Vascular Diseases

China
Fruitura Bioscience Ltd.

Completed

Effect of Red Grape Cells (RGC) Powder Consumption on Measures of Aerobic Fitness and Mood

Healthy

Israel
Bayer

Completed

A Prospective Multicenter Study on Patients'Satisfaction With Angeliq® Micro in Real Clinical Practice Conducted in Russia

Menopause

Russian Federation
Scandinavian Critical Care Trials Group
Rigshospitalet, Denmark; University of Copenhagen; Copenhagen Trial Unit, Center...

Completed

Transfusion-requirements in Septic Shock Trial (TRISS)

Septic Shock

Sweden, Norway, Finland, Denmark
Bayer

Completed

Cycle Control and Safety of E2-DRSP

Contraceptive, Oral, Hormonal

Germany
ES Therapeutics Australia Pty Ltd

Recruiting

Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy

Drug Resistant Epilepsy

Australia
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) (SCD-CARRE)

Sickle Cell Disease

United States, France, Brazil
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Recruiting

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

Coronavirus Infections | COVID-19

United Arab Emirates
Bayer

Completed

Identification of Hepatic Lesions

Hepatic Neoplasms

Italy
Alfredo Gamboa
Vanderbilt University Medical Center

Active, not recruiting

Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)

Postural Tachycardia Syndrome | Postural Orthostatic Tachycardia Syndrome

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

Red Cell Transfusion Goals in Patients With Acute Leukemias

Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia (AML) | Acute Lymphocytic Leukemia (ALL) | Acute Promyelocytic Leukemia (APL)

United States
Alume Biosciences, Inc.
Ergomed

Recruiting

Feasibility Study- REVEAL 475 for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery

Head and Neck Surgery

United States
Alume Biosciences, Inc.

Completed

A Study of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery

Head and Neck Neoplasms | Surgery | Thyroid Neoplasms | Nerve Injury | Parotid Neoplasm | Imaging

United States
Hasselt University
Université de Parakou

Recruiting

High-Intensity Interval Training in the Early Subacute Stroke With a Semi-recumbent Bike

Stroke, Acute

Belgium

Search clinical trials for: REC-4881

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations